Altix Alt.1
FundsPrivate Equity·Nederlandse versie

Altix Alt.1

Managed by Altix Capital

Altix Alt.1

Altix Capital logo

Managed by

Altix Capital
UnverifiedUnverified

Associated with this fund?

Claim this fund →
Altix Alt.1 banner
Altix Alt.1 is the first fund-of-funds from Amsterdam-based Altix: a Dutch cooperative that closed in March 2024 with €60 million from 150+ private investors (20% above target) and commits to five institutional mid-market private equity funds — Rivean Capital, Gilde Healthcare, Quadrum Capital, Inflexion and Axcel Partners. Target 2.0–2.5x over a 12-year term, 1% management fee, no Altix carry, €100,000 minimum. Closed to new investors.

Key Statistics

Fund Size

€60M

Target Return

8.8%

Launch Year

2023

Min. Investment

€100,000

Availability

Closed

Structure

Coöperatief

Product Category

Closed-end

Domicile

Netherlands

GP Type

Multi

Liquidity Level

Low (5+ years)

Management Fee

1%

Carry

None%

High Water Mark

No

Currencies

EUR

Investor Eligibility

Retail

Liquidity Options

12

Highlights

€60M closed March 2024, 20% above target, 150+ investors
Five underlying funds: Rivean, Gilde Healthcare, Quadrum, Inflexion, Axcel
Target 2.0–2.5x invested capital over 12 years
1% management fee, no carried interest at Altix level
Closed to new investors; capital locked for 12 years

Key Information Document (KID) – EU Funds

KID Risk Indicator

6 out of 7

1
2
3
4
5
6
7
Low risk / Low rewardHigh risk / High reward

Annual Returns (KID Scenarios)

Stressed

-4.37%

Moderate

6%

Favorable

8.77%

Average Total Cost Level (KID)

4.8%

Allocations

Geographic Focus

Investment Strategy

Buyout
Growth Equity
Venture Capital

Industry Focus

Diversified
Healthcare

Portfolio Composition

Rivean Capital
Gilde Healthcare
Quadrum Capital
Inflexion
Axcel Partners

Information about fund

Altix’s First Fund: €60 Million into Five Mid-Market Funds

Altix Alt.1 was the first fund from Amsterdam-based Altix, and it set the template the firm has followed since: a Dutch cooperative owned by private investors that pools their money and commits it to a handful of institutional private equity funds that typically demand tickets of several million euros. Alt.1 closed on 26 March 2024 with some €60 million from more than 150 investors, 20% above its €50 million target, and is no longer open to new investors.

Key Figures

Fund Size

€60M

Closed 26 Mar 2024, target €50M

Investors

150+

Dutch private investors

Underlying Funds

5

Rivean, Gilde Healthcare, Quadrum, Inflexion, Axcel

Target Multiple

2.0–2.5x

Over 12-year term

Fees

1% / no carry

Underlying fund fees apply

Liquidity

None

12-year lock-up

Portfolio

The portfolio consists of five underlying funds: Rivean Capital, Gilde Healthcare, Quadrum Capital, Inflexion and Axcel Partners — well-established Dutch, British and Nordic managers operating in the mid-market buyout and growth space. At the time of the close those funds had made 16 investments on Alt.1’s behalf; Altix expects the final look-through portfolio to comprise 80 to 100 companies. Invested capital is targeted to return 2.0 to 2.5 times over the fund’s twelve-year life.

Underlying Funds

Rivean CapitalBenelux/DACH mid-market buyouts (formerly Gilde Buy Out Partners)
Gilde HealthcareHealthcare buyouts and growth, Netherlands
Quadrum CapitalDutch lower mid-market buyouts
InflexionUK mid-market private equity
Axcel PartnersNordic mid-market buyouts

Terms

Terms are straightforward by private equity standards: the minimum subscription was €100,000, the management fee is 1%, and — in a deviation from the industry norm — Altix charges no carried interest of its own, although the underlying funds charge theirs. There is no liquidity: capital remains locked for the full twelve years, and distributions arrive only as the underlying funds sell companies. The KID classifies the fund as risk class 6 of 7, with a moderate scenario of 6% a year and total costs of 4.8% a year including the underlying funds’ fees.

Explore further

This is an unverified fund profile written by FundScouter and may contain inaccuracies.

Are you affiliated with this fund? Claim this fund to verify and manage your fund profile.